drugset / Trial / NCT01505426

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

NCT01505426

Phase 3 Completed 171 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy and safety of ASP1941 + metformin with metformin alone in Asian subjects with type 2 diabetes mellitus.

Timeline

Start
2011-11-28
Primary completion
2013-01-14
Completion
2013-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral
Background Metformin Small molecule Oral